Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kulczycki

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Clinical Immunology and Immunopathology|October 1, 1992
Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitisP D Mehta, J Kulczycki, S P Mehta, et al.
Folia Neuropathologica|January 1, 1996
Adult schizophrenic-like variant of adrenoleukodystrophyG M Szpak, E Lewandowska, B Schmidt-Sidor, et al.
Journal of Neuropathology and Experimental Neurology|September 16, 1998
Cell-type-specific enhancement of amyloid-beta deposition in a novel presenilin-1 mutation (P117L)J Wegiel, H M Wisniewski, I Kuchna, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|February 7, 2022
Efficacy and safety of shockwave intravascular lithotripsy (S-IVL) in calcified unprotected left main percutaneous coronary intervention - short-term outcomesPiotr Rola, Adrian Włodarczak, Jan J Kulczycki, et al.
Neurologia I Neurochirurgia Polska|January 1, 1989
[Clinical diagnosis of Jakob-Creutzfeldt syndrome--analysis of 6 cases]K Honczarenko, J Kulczycki, C Fryze, et al.
Neuroreport|March 21, 1998
A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 yearsT Wisniewski, W K Dowjat, J D Buxbaum, et al.
Polish Archives of Internal Medicine|April 7, 2025
Effectiveness of coronary sinus reducer implantation in routine clinical practice: 12-month outcomesSzymon Włodarczak, Piotr Rola, Artur Jastrzębski, et al.
Cardiology Journal|May 27, 2022
Outcomes of the two generations of bioresorbable scaffolds (Magmaris vs. Absorb) in acute coronary syndrome in routine clinical practicePiotr Rola, Adrian Włodarczak, Magdalena Łanocha, et al.
European Journal of Neurology|January 26, 2007
CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathiesA Green, P Sanchez-Juan, A Ladogana, et al.
Neurology|August 23, 2006
CSF tests in the differential diagnosis of Creutzfeldt-Jakob diseaseP Sanchez-Juan, A Green, A Ladogana, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Clinical Immunology and Immunopathology|October 1, 1992
Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitisP D Mehta, J Kulczycki, S P Mehta, et al.
Folia Neuropathologica|January 1, 1996
Adult schizophrenic-like variant of adrenoleukodystrophyG M Szpak, E Lewandowska, B Schmidt-Sidor, et al.
Journal of Neuropathology and Experimental Neurology|September 16, 1998
Cell-type-specific enhancement of amyloid-beta deposition in a novel presenilin-1 mutation (P117L)J Wegiel, H M Wisniewski, I Kuchna, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|February 7, 2022
Efficacy and safety of shockwave intravascular lithotripsy (S-IVL) in calcified unprotected left main percutaneous coronary intervention - short-term outcomesPiotr Rola, Adrian Włodarczak, Jan J Kulczycki, et al.
Neurologia I Neurochirurgia Polska|January 1, 1989
[Clinical diagnosis of Jakob-Creutzfeldt syndrome--analysis of 6 cases]K Honczarenko, J Kulczycki, C Fryze, et al.
Neuroreport|March 21, 1998
A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 yearsT Wisniewski, W K Dowjat, J D Buxbaum, et al.
Polish Archives of Internal Medicine|April 7, 2025
Effectiveness of coronary sinus reducer implantation in routine clinical practice: 12-month outcomesSzymon Włodarczak, Piotr Rola, Artur Jastrzębski, et al.
Cardiology Journal|May 27, 2022
Outcomes of the two generations of bioresorbable scaffolds (Magmaris vs. Absorb) in acute coronary syndrome in routine clinical practicePiotr Rola, Adrian Włodarczak, Magdalena Łanocha, et al.
European Journal of Neurology|January 26, 2007
CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathiesA Green, P Sanchez-Juan, A Ladogana, et al.
Neurology|August 23, 2006
CSF tests in the differential diagnosis of Creutzfeldt-Jakob diseaseP Sanchez-Juan, A Green, A Ladogana, et al.
Pageof 8